Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

X-Chromosome inactivation analysis in different cell types and induced pluripotent stem cells elucidates the disease mechanism in a rare case of mucopolysaccharidosis type II in a female

M. Řeboun, J. Rybová, R. Dobrovolný, J. Včelák, T. Veselková, G. Štorkánová, D. Mušálková, M. Hřebíček, J. Ledvinová, M. Magner, J. Zeman, K. Pešková, L. Dvořáková

. 2016 ; 62 (2) : 82-89.

Jazyk angličtina Země Česko

Typ dokumentu kazuistiky, časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc17010391

Grantová podpora
NT14015 MZ0 CEP - Centrální evidence projektů
NV15-33297A MZ0 CEP - Centrální evidence projektů

Mucopolysaccharidosis type II (MPS II) is an X-linked lysosomal storage disorder resulting from deficiency of iduronate-2-sulphatase activity. The disease manifests almost exclusively in males; only 16 symptomatic heterozygote girls have been reported so far. We describe the results of X-chromosome inactivation analysis in a 5-year-old girl with clinically severe disease and heterozygous mutation p.Arg468Gln in the IDS gene. X inactivation analysed at three X-chromosome loci showed extreme skewing (96/4 to 99/1) in two patient's cell types. This finding correlated with exclusive expression of the mutated allele. Induced pluripotent stem cells (iPSC) generated from the patient's peripheral blood demonstrated characteristic pluripotency markers, deficiency of enzyme activity, and mutation in the IDS gene. These cells were capable of differentiation into other cell types (cardiomyocytes, neurons). In MPS II iPSC clones, the X inactivation ratio remained highly skewed in culture conditions that led to partial X inactivation reset in Fabry disease iPSC clones. Our data, in accordance with the literature, suggest that extremely skewed X inactivation favouring the mutated allele is a crucial condition for manifestation of MPS II in females. This suggests that the X inactivation status and enzyme activity have a prognostic value and should be used to evaluate MPS II in females. For the first time, we show generation of iPSC from a symptomatic MPS II female patient that can serve as a cellular model for further research of the pathogenesis and treatment of this disease.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17010391
003      
CZ-PrNML
005      
20201112211751.0
007      
ta
008      
170320s2016 xr ad f 000 0|eng||
009      
AR
024    __
$a 10.14712/fb2016062020082 $2 doi
035    __
$a (PubMed)27187040
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Řeboun, Martin. $u Institute of Inherited Metabolic Disorders, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Czech Republic $7 xx0229675
245    10
$a X-Chromosome inactivation analysis in different cell types and induced pluripotent stem cells elucidates the disease mechanism in a rare case of mucopolysaccharidosis type II in a female / $c M. Řeboun, J. Rybová, R. Dobrovolný, J. Včelák, T. Veselková, G. Štorkánová, D. Mušálková, M. Hřebíček, J. Ledvinová, M. Magner, J. Zeman, K. Pešková, L. Dvořáková
520    9_
$a Mucopolysaccharidosis type II (MPS II) is an X-linked lysosomal storage disorder resulting from deficiency of iduronate-2-sulphatase activity. The disease manifests almost exclusively in males; only 16 symptomatic heterozygote girls have been reported so far. We describe the results of X-chromosome inactivation analysis in a 5-year-old girl with clinically severe disease and heterozygous mutation p.Arg468Gln in the IDS gene. X inactivation analysed at three X-chromosome loci showed extreme skewing (96/4 to 99/1) in two patient's cell types. This finding correlated with exclusive expression of the mutated allele. Induced pluripotent stem cells (iPSC) generated from the patient's peripheral blood demonstrated characteristic pluripotency markers, deficiency of enzyme activity, and mutation in the IDS gene. These cells were capable of differentiation into other cell types (cardiomyocytes, neurons). In MPS II iPSC clones, the X inactivation ratio remained highly skewed in culture conditions that led to partial X inactivation reset in Fabry disease iPSC clones. Our data, in accordance with the literature, suggest that extremely skewed X inactivation favouring the mutated allele is a crucial condition for manifestation of MPS II in females. This suggests that the X inactivation status and enzyme activity have a prognostic value and should be used to evaluate MPS II in females. For the first time, we show generation of iPSC from a symptomatic MPS II female patient that can serve as a cellular model for further research of the pathogenesis and treatment of this disease.
650    _2
$a kultivované buňky $7 D002478
650    _2
$a předškolní dítě $7 D002675
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a iduronátsulfatasa $x genetika $x metabolismus $7 D007066
650    12
$a indukované pluripotentní kmenové buňky $7 D057026
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a mukopolysacharidóza II $x diagnóza $x enzymologie $x genetika $7 D016532
650    _2
$a mutace $7 D009154
650    12
$a inaktivace chromozomu X $7 D049951
655    _2
$a kazuistiky $7 D002363
655    _2
$a časopisecké články $7 D016428
700    1_
$a Rybová, Jitka. $u Institute of Inherited Metabolic Disorders, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Czech Republic $7 xx0228204
700    1_
$a Dobrovolný, Robert $u Institute of Inherited Metabolic Disorders, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Czech Republic $7 xx0063743
700    1_
$a Včelák, Josef, $u Institute of Inherited Metabolic Disorders, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Czech Republic $d 1971- $7 xx0107261
700    1_
$a Veselková, T. $u Institute of Inherited Metabolic Disorders, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Czech Republic $7 _AN090897
700    1_
$a Štorkánová, Gabriela $u Institute of Inherited Metabolic Disorders, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Czech Republic $7 xx0246969
700    1_
$a Mušálková, Dita $u Institute of Inherited Metabolic Disorders, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Czech Republic $7 xx0207777
700    1_
$a Hřebíček, Martin, $u Institute of Inherited Metabolic Disorders, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Czech Republic $d 1961- $7 xx0077429
700    1_
$a Ledvinová, Jana, $u Institute of Inherited Metabolic Disorders, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Czech Republic $d 1943- $7 jo2003163160
700    1_
$a Magner, Martin $u Department of Paediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Czech Republic $7 xx0084624
700    1_
$a Zeman, Jiří, $u Department of Paediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Czech Republic $d 1950- $7 skuk0001517
700    1_
$a Pešková, Karolína $u Institute of Inherited Metabolic Disorders, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Czech Republic $7 xx0172216
700    1_
$a Dvořáková, Lenka $u Institute of Inherited Metabolic Disorders, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Czech Republic $7 xx0060521
773    0_
$w MED00011004 $t Folia biologica $x 0015-5500 $g Roč. 62, č. 2 (2016), s. 82-89
856    41
$u http://fb.cuni.cz/ $y domovská stránka časopisu
910    __
$a ABA008 $b A 970 $c 89 $y 4 $z 0
990    __
$a 20170320 $b ABA008
991    __
$a 20201112211748 $b ABA008
999    __
$a ok $b bmc $g 1196575 $s 971107
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 62 $c 2 $d 82-89 $i 0015-5500 $m Folia biologica (Praha) $n Folia biol. (Praha) $x MED00011004
GRA    __
$a NT14015 $p MZ0
GRA    __
$a NV15-33297A $p MZ0
LZP    __
$b NLK118 $a Pubmed-20170320

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...